Immunotherapy touted in annual Cancer Report

Lung cancer and some otherwise incurable blood cancers are increasingly being treated with forms of immunotherapy.

And it's an effective way, according to the annual Clinical Cancer Advances report. The American Society of Clinical Oncology estimates that one in four patients with newly discovered lung cancer, with immune checkpoint inhibitors treatment, may live ten years beyond initial diagnoses.

The report also names CAR T-cell therapy, which uses a patient's own white blood cells against blood cancer, as the advance of the year in cancer care.